Vir Biotechnology (VIR) Current Assets (2018 - 2026)

Vir Biotechnology's Current Assets history runs 9 years deep, the most recent figure standing at $523.0 million for Q1 2026.

• In Q1 2026, Current Assets fell 43.9% year-over-year to $523.0 million; the TTM figure through Mar 2026 stood at $523.0 million (down 43.9% YoY), while the FY2025 annual figure was $514.1 million, down 50.69% from the prior year.
• Current Assets came in at $523.0 million for Q1 2026 at Vir Biotechnology, up from $514.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.6 billion in Q1 2022 to a low of $514.1 million in Q4 2025.
• A 5-year average of $1.5 billion and a median of $1.2 billion in 2024 frame the typical range for Current Assets.
• Across the five-year window, Current Assets jumped 165.37% in 2022 and sank 50.69% in 2025, its largest moves.
• Vir Biotechnology's Current Assets stood at $2.5 billion in 2022, then sank by 36.95% to $1.6 billion in 2023, then sank by 34.36% to $1.0 billion in 2024, then tumbled by 50.69% to $514.1 million in 2025, then increased by 1.73% to $523.0 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $523.0 million, $514.1 million, and $545.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison